Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Bertrand

Showing results (111-120 of 155) with videos related to

Pageof 16
Sort By:
Plos One|April 22, 2021
Intensity of de novo DSA detected by Immucor Lifecodes assay and C3d fixing antibodies are not predictive of subclinical ABMR after Kidney TransplantationDominique Bertrand, Rangolie Kaveri, Charlotte Laurent, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 6, 2023
Impact of Calcineurin Inhibitor-Based Immunosuppression Maintenance During the Dialysis Period After Kidney Transplant Failure on the Next Kidney Graft Outcome: A Retrospective Multicenter Study With Propensity Score AnalysisJuliette Noelle, Valentin Mayet, Céline Lambert, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 4, 2025
Belatacept in Kidney Transplantation: Reflecting on the Past, Shaping the FutureJohan Noble, Juliette Leon, Arnaud Del Bello, et al.
Transplantation Direct|November 22, 2021
SARS-CoV-2-specific Humoral and Cellular Immunities in Kidney Transplant Recipients and Dialyzed Patients Recovered From Severe and Nonsevere COVID-19Dominique Bertrand, Mouad Hamzaoui, Laurent Drouot, et al.
Journal of the American Society of Nephrology : JASN|January 19, 2017
Anti-Factor B and Anti-C3b Autoantibodies in C3 Glomerulopathy and Ig-Associated Membranoproliferative GNMaria Chiara Marinozzi, Lubka T Roumenina, Sophie Chauvet, et al.
Kidney International|October 7, 2021
Antibody and T-cell response to a third dose of SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipientsDominique Bertrand, Mouad Hamzaoui, Veronique Lemée, et al.
Kidney International Reports|October 21, 2024
Imlifidase in Highly Sensitized Kidney Transplant Recipients With a Positive Crossmatch Against a Deceased DonorNassim Kamar, Dominique Bertrand, Sophie Caillard, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 19, 2015
Eight-year results of the Spiesser study, a randomized trial comparing de novo sirolimus and cyclosporine in renal transplantationPhilippe Gatault, Dominique Bertrand, Matthias Büchler, et al.
Clinical Kidney Journal|August 4, 2021
Belatacept-based immunosuppressive regimen in HIV-positive kidney transplant recipientsKarim El Sakhawi, Giovanna Melica, Anne Scemla, et al.
Kidney International Reports|September 18, 2024
Immunoadsorption and Plasma Exchange are Comparable in Anti-Neutrophil Cytoplasmic Antibodies or Anti-Glomerular Basement Membrane Removal KineticsMarion Sallee, Noémie Resseguier, Thomas Crepin, et al.
Pageof 16

Showing results (111-120 of 155) with videos related to

Sort By:
Pageof 16
Plos One|April 22, 2021
Intensity of de novo DSA detected by Immucor Lifecodes assay and C3d fixing antibodies are not predictive of subclinical ABMR after Kidney TransplantationDominique Bertrand, Rangolie Kaveri, Charlotte Laurent, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 6, 2023
Impact of Calcineurin Inhibitor-Based Immunosuppression Maintenance During the Dialysis Period After Kidney Transplant Failure on the Next Kidney Graft Outcome: A Retrospective Multicenter Study With Propensity Score AnalysisJuliette Noelle, Valentin Mayet, Céline Lambert, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 4, 2025
Belatacept in Kidney Transplantation: Reflecting on the Past, Shaping the FutureJohan Noble, Juliette Leon, Arnaud Del Bello, et al.
Transplantation Direct|November 22, 2021
SARS-CoV-2-specific Humoral and Cellular Immunities in Kidney Transplant Recipients and Dialyzed Patients Recovered From Severe and Nonsevere COVID-19Dominique Bertrand, Mouad Hamzaoui, Laurent Drouot, et al.
Journal of the American Society of Nephrology : JASN|January 19, 2017
Anti-Factor B and Anti-C3b Autoantibodies in C3 Glomerulopathy and Ig-Associated Membranoproliferative GNMaria Chiara Marinozzi, Lubka T Roumenina, Sophie Chauvet, et al.
Kidney International|October 7, 2021
Antibody and T-cell response to a third dose of SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipientsDominique Bertrand, Mouad Hamzaoui, Veronique Lemée, et al.
Kidney International Reports|October 21, 2024
Imlifidase in Highly Sensitized Kidney Transplant Recipients With a Positive Crossmatch Against a Deceased DonorNassim Kamar, Dominique Bertrand, Sophie Caillard, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 19, 2015
Eight-year results of the Spiesser study, a randomized trial comparing de novo sirolimus and cyclosporine in renal transplantationPhilippe Gatault, Dominique Bertrand, Matthias Büchler, et al.
Clinical Kidney Journal|August 4, 2021
Belatacept-based immunosuppressive regimen in HIV-positive kidney transplant recipientsKarim El Sakhawi, Giovanna Melica, Anne Scemla, et al.
Kidney International Reports|September 18, 2024
Immunoadsorption and Plasma Exchange are Comparable in Anti-Neutrophil Cytoplasmic Antibodies or Anti-Glomerular Basement Membrane Removal KineticsMarion Sallee, Noémie Resseguier, Thomas Crepin, et al.
Pageof 16